Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Adult Immune Responses to Vaccine”

196 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 196 results

Early research (Phase 1)Active Not RecruitingNCT07428759
What this trial is testing

Trial to Evaluate Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults Aged 50 To 64 Years

Who this might be right for
Pneumonia, Bacterial
GlaxoSmithKline 121
Early research (Phase 1)Study completedNCT02997969
What this trial is testing

Safety and Immune Response to a Clade C DNA HIV Vaccine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 132
Testing effectiveness (Phase 2)Study completedNCT02529904
What this trial is testing

ADITEC FLU 2 STUDY: Understanding the Genetics Basis for Immune Responses to Flu Vaccines in Children and Adults

Who this might be right for
Influenza
University of Oxford 120
Large-scale testing (Phase 3)Study completedNCT00474487
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
Novartis Vaccines 2,831
Early research (Phase 1)Study completedNCT01441167
What this trial is testing

Experimental PfSPZ Vaccine in Adults Without Malaria

Who this might be right for
MalariaPrevention and ControlAcquired Immunity
National Institute of Allergy and Infectious Diseases (NIAID) 64
Testing effectiveness (Phase 2)Active Not RecruitingNCT06803342
What this trial is testing

A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Sudan Ebolavirus Vaccine in Healthy Adults

Who this might be right for
Ebola Sudan Virus Disease
Albert B. Sabin Vaccine Institute 200
Post-approval studies (Phase 4)Looking for participantsNCT07177417
What this trial is testing

Characterizing the Human Airway Immune Response to FluMist Vaccination

Who this might be right for
Healthy Young AdultsInfluenza VaccinesInfluenza Vaccine Response
Washington University School of Medicine 30
Testing effectiveness (Phase 2)Study completedNCT01393951
What this trial is testing

Evaluate the Immune Response to the ASP7374 and Its Safety in Healthy Adult Volunteers

Who this might be right for
HealthyImmunogenicity of ASP7374
UMN Pharma Inc. 165
Early research (Phase 1)Study completedNCT00428337
What this trial is testing

Safety of and Immune Response to a DNA Vaccine and a Recombinant HIV-1-MVA Vaccine, Separately and in Combination, in Healthy Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Early research (Phase 1)Study completedNCT03713086
What this trial is testing

Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy Adults

Who this might be right for
Rabies
CureVac 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT06620003
What this trial is testing

A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Marburg Virus Vaccine in Healthy Adults

Who this might be right for
Marburg Virus Disease
Albert B. Sabin Vaccine Institute 200
Testing effectiveness (Phase 2)Study completedNCT05921903
What this trial is testing

A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 386
Early research (Phase 1)Study completedNCT02109354
What this trial is testing

Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy Adults

Who this might be right for
HIV Infection
HIV Vaccine Trials Network 202
Early research (Phase 1)Study completedNCT00347672
What this trial is testing

Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 42
Early research (Phase 1)Study completedNCT00919178
What this trial is testing

Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus

Who this might be right for
Dengue Shock SyndromeDengue Hemorrhagic Fever
National Institute of Allergy and Infectious Diseases (NIAID) 70
Early research (Phase 1)Study completedNCT03958799
What this trial is testing

Describe the Safety Profile and Compare the Immune Response of 4 Different Formulations of an Investigational Tdap Vaccine When Compared to Licensed Tdap Vaccine in Young Adults in Canada

Who this might be right for
Tetanus Immunisation (Healthy Volunteers)Diphtheria Immunisation (Healthy Volunteers)Pertussis Immunisation (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 71
Early research (Phase 1)Study completedNCT02057263
What this trial is testing

The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults

Who this might be right for
Hepatitis B
Massachusetts General Hospital 28
Early research (Phase 1)Study completedNCT00366782
What this trial is testing

Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and Adults

Who this might be right for
Paramyxoviridae InfectionsVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 51
Early research (Phase 1)Study completedNCT02296541
What this trial is testing

Evaluating the Safety and Immune Response to Three Different DNA HIV Vaccines Administered With a MVA-CMDR Boost Vaccine in Healthy, HIV-Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 105
Testing effectiveness (Phase 2)Study completedNCT05089630
What this trial is testing

Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults

Who this might be right for
Cytomegalovirus Infections
GlaxoSmithKline 339
Load More Results